Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-1997 | 03-1997 | |
| Sales | 2,099 | 1,508 |
| Gross Profit | 2,099 | 1,508 |
| Operating Income | 2,099 | 1,508 |
| Pre-tax Income | 2,099 | 1,508 |
| Net Income Continuous | 509 | 75 |
| Net Income | $509 | $75 |
| EPS Basic Total Ops | 0.03 | 0.01 |
| EPS Basic Continuous Ops | 0.03 | 0.01 |
| EPS Diluted Total Ops | 0.02 | 0.01 |
| EPS Diluted Continuous Ops | 0.03 | 0.01 |
| EBITDA(a) | $2,099 | $1,508 |